DNAE
LIVE

Serial Number

98563271

Owner

DNAe Group Holdings Limited

Attorney

Rebecca Liebowitz

Filing Date

May 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DNAE Trademark

Serial Number: 98563271

DNAE is a trademark filed by DNAe Group Holdings Limited on May 22, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

DNAe Group Holdings Limited (4 trademarks)

58 Wood Lane
London W127RZ , GB

Entity Type: 24

Trademark Details

Filing Date

May 22, 2024

Registration Date

Not Registered

Goods & Services

(Based on 44(d))(Based on Intent To Use) Apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for on-chip DNA and RNA amplification sequencing and measurement; downloadable computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; semiconductors and microchips for sequencing and measurement of DNA for medical and veterinary purposes; all of the foregoing for scientific research purposes, not pertaining to the dnaE gene; (Based on Intent To Use) Scientific apparatus and instruments, namely, apparatus for conducting genomic analysis; scientific research and laboratory apparatus, namely, apparatus for conducting genomic analysis; apparatus for conducting PCR analysis; apparatus for semiconductor sequencing; silicon transistors; microchips; data processing equipment; downloadable computer software for genomic analysis; downloadable bioinformatics software; downloadable software for microbial pathogen detection and identification; all of the foregoing for scientific research purposes, not pertaining to the dnaE gene

(Based on 44(d))(Based on Intent To Use) DNA and RNA screening for medical purposes; medical laboratory services for the analysis of samples taken from patients; provision of medical information relating to the analysis of DNA and RNA; medical consultancy and advisory services relating to the aforesaid services; (Based on Intent To Use) Medical and veterinary services; healthcare services; medical genetic and blood testing, sequencing and measuring services provided by medical laboratories; genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical consultancy and advisory services relating to the aforesaid services

(Based on 44(d))(Based on Intent To Use) Apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; medical apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; medical diagnostic apparatus for the diagnosis and monitoring of cancer; medical diagnostic apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; (Based on Intent To Use) Medical and veterinary apparatus and instruments for use in molecular diagnostics; medical diagnostic apparatus for microbial pathogen detection and identification; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection

(Based on 44(d))(Based on Intent To Use) Medical research laboratory services in the testing, sequencing and measurement of DNA and RNA; electronic data storage services; consultancy and advisory services relating to the aforesaid services; none of the preceding pertaining to the dnaE gene; (Based on Intent To Use) Scientific and technological services, namely, scientific research, analysis, and testing in the field of genomic analysis; medical research laboratory services; research laboratory analysis; consultancy and advisory services related to the aforesaid services; none of the preceding pertaining to the dnaE gene

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 12, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 12, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 12, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 27, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 26, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 26, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 26, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 10, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2024 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 12, 2024 AMPX
ASSIGNED TO LIE
Nov 12, 2024 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 26, 2024 PARI
NEW APPLICATION ENTERED
May 22, 2024 NWAP